The worldwide fertility rates is declining, so they are perfectly positioned to capitalize on the increasing demand for IVF services. Much growth potential in this counter
From Aminvest -Retain BUY on Alpha IVF with unchanged FV of RM0.42, based on 28x CY25 PE. We attach a 3-star ESG rating to Alpha IVF. Our earnings forecast remains unchanged as the Group's 1QFY25 core net profit tracking expectation at 21.3% of our full year estimates.
They offers additional Assisted Reproductive Technology (ART) services too, such as ICSI, IUI, diagnostics, testing, screening procedures, and cryopreservation of eggs, sperm, and embryos.
Keep top up Alpha, where the comapny has a dividend policy which plans to pay out a minimum of 60% of its earnings as dividends, translating to a 2.3% dividend yield in FY24.
ALPHA will be the SEA regional leader in fertility care with more expansion into Indonesia and the Philippines, stay for the long term growth & dividend
NOSH is too high in the market! For it to move, it really needs a very high volume trade. DY will be low too, unless the revenue and margin grow significantly.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
growthstockhunter
49 posts
Posted by growthstockhunter > 2 weeks ago | Report Abuse
The worldwide fertility rates is declining, so they are perfectly positioned to capitalize on the increasing demand for IVF services. Much growth potential in this counter